| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,442,668 ) |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA279795 | Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence | 000 | 2 | NIH | 1/23/2025 | $509,593 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI180152 | Dysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging | 000 | 2 | NIH | 3/11/2025 | $639,037 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 000 | 5 | NIH | 3/6/2025 | $551,334 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01DK135683 | Genetic studies linking LSP1 function in T cells to Inflammatory Bowel Disease | 000 | 3 | NIH | 3/5/2025 | $362,340 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI180800 | Understanding pH-dependent receptor utilization of Lassa virus | 000 | 2 | NIH | 3/11/2025 | $221,888 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI187062 | Towards a predictive understanding of influenza immunity through experimental data integration, iterative model development, and rigorous assessment of model quality | 000 | 1 | NIH | 12/19/2024 | $1,246,617 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37AI125068 | Maximizing germinal centers and somatic hypermutation to HIV Env immunogens | 000 | 10 | NIH | 1/17/2025 | $874,385 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI180456 | What is the human antibody response to measles virus vaccination? | 000 | 2 | NIH | 11/6/2024 | $221,888 |
| | 2025 | 2025 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI180853 | Illuminating Lujo virus glycoprotein structure, receptor engagement and neutralizing antibody epitopes | 000 | 2 | NIH | 10/25/2024 | $221,888 |
| | 2025 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA260588 | SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects | 003 | 2 | NIH | 3/27/2025 | $0 |
| | 2025 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 000 | 10 | NIH | 2/20/2025 | $0 |
| | 2025 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 000 | 3 | NIH | 3/25/2025 | $0 |
| | 2025 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 001 | 6 | NIH | 1/22/2025 | $5,217 |
| | 2025 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM128938 | Studying the function of human genetic variation in the light of 3D genome organization | 000 | 7 | NIH | 11/6/2024 | $0 |
| | 2025 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI163665 | Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma | 000 | 2 | NIH | 3/25/2025 | -$70,013 |
| | 2025 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA260588 | SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects | 002 | 2 | NIH | 3/27/2025 | $0 |
| | 2025 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37CA276779 | Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy | 000 | 1 | NIH | 3/14/2025 | -$6,734 |
| | 2025 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 000 | 5 | NIH | 1/22/2025 | -$5,217 |
| | 2025 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI092453 | Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes | 000 | 11 | NIH | 1/23/2025 | -$329,555 |
| | 2025 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA260588 | SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects | 001 | 2 | NIH | 3/27/2025 | $0 |
| | 2025 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI040127 | Signal transduction and gene induction in lymphocytes | 000 | 30 | NIH | 12/20/2024 | $0 |
| | 2025 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI146042 | Histamine-Releasing Factor Oligomers in Food Allergy | 000 | 4 | NIH | 2/11/2025 | $0 |
| | 2025 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 002 | 4 | NIH | 1/22/2025 | $0 |
| | 2025 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R03OD034494 | Using Common Fund datasets for prioritization of disease-associated genetic variants | 000 | 1 | NIH | 12/30/2024 | $0 |
| | 2025 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA260588 | SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects | 000 | 1 | NIH | 3/13/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $55,603,074 ) (Continued on the next page) |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI173927 | Experimental identification of functional GWAS variants linked to COVID-19 severity in immune cells | 000 | 2 | NIH | 4/17/2024 | $274,500 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI180801 | Filovirus nucleocapsid assembly, caught in the act, by in situ structural biology | 000 | 1 | NIH | 5/24/2024 | $247,050 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA279795 | Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence | 000 | 1 | NIH | 4/9/2024 | $573,738 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI170010 | Dynamic analysis of beta cell attacks in response to virus infection in Human pancreatic slices | 001 | 2 | NIH | 5/23/2024 | $22,875 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI170010 | Dynamic analysis of beta cell attacks in response to virus infection in Human pancreatic slices | 000 | 2 | NIH | 2/9/2024 | $205,875 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM147554 | Elucidating the signaling and protein interaction networks of the O-GlcNAc transferase during embryonic stem cell state transitions | 001 | 3 | NIH | 5/9/2024 | $89,433 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM147554 | Elucidating the signaling and protein interaction networks of the O-GlcNAc transferase during embryonic stem cell state transitions | 000 | 3 | NIH | 5/8/2024 | $457,500 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI163188 | Development of a Replicon RNA-based Vaccine against Dengue and Zika | 000 | 4 | NIH | 5/9/2024 | $721,849 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 001 | 4 | NIH | 5/24/2024 | $56,838 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 000 | 4 | NIH | 2/22/2024 | $511,547 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA256133 | Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy | 000 | 4 | NIH | 6/20/2024 | $659,355 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM128938 | Studying the function of human genetic variation in the light of 3D genome organization | 002 | 7 | NIH | 9/10/2024 | $21,151 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM128938 | Studying the function of human genetic variation in the light of 3D genome organization | 001 | 7 | NIH | 8/1/2024 | $494,100 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 003 | 3 | NIH | 5/16/2024 | $469,233 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 001 | 3 | NIH | 3/20/2024 | $445,252 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 000 | 8 | NIH | 6/7/2024 | $328,919 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 001 | 36 | NIH | 5/29/2024 | $84,234 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 000 | 36 | NIH | 2/27/2024 | $758,119 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI180152 | Dysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging | 000 | 1 | NIH | 3/20/2024 | $658,800 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI178427 | Structure of the SARS-CoV-2 Nucleocapsid: building block to viral capsid | 000 | 2 | NIH | 7/9/2024 | $229,720 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA247500 | Exploring the potential of TET inhibition in cancer immunotherapy | 000 | 5 | NIH | 6/14/2024 | $477,498 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA247500 | Exploring the potential of TET inhibition in cancer immunotherapy | 001 | 5 | NIH | 6/18/2024 | $99,352 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI128589 | Investigating the role of TET deficiency in promoting T cell expansion and inflammation | 002 | 8 | NIH | 7/5/2024 | -$549,000 |
|
